Bringing the fundamentals into focus…
Back to Haemonetics Corporation
How Haemonetics Corporation stacks up
HAE · against 223 other Healthcare companies of similar size
Overall
43/ 100
Near the bottom of its peers.
Ranked #167 of 224 · scores higher than 24% of peers
Bars: peers in each 10-point band of the overall score34 peers with an overall score of 40–49, including HAE · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around HAE| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 3 | 18.3B DKK (≈$2.7B) | 81 | 86 | 74 | 86 | 0 / 2 | |
| 4 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 5 | 40.3B SEK (≈$4.0B) | 79 | 43 | 84 | 97 | 0 / 2 | |
| 163 | 6.2B USD | 44 | 8 | 82 | 10 | 0 / 2 | |
| 163 | 4.2B USD | 44 | 8 | 93 | 23 | 1 / 2 | |
| 167 | 10.0B USD | 43 | 52 | 25 | 50 | 1 / 2 | |
| 167 | 7.2B USD | 43 | 48 | 57 | 40 | 2 / 2 | |
| 167 | 5.5B USD | 43 | 53 | 24 | 76 | 2 / 2 | |
| 167 | 3.6B USD | 43 | 85 | 15 | 69 | 2 / 2 | |
| 171 | 29.2B CNY (≈$4.1B) | 42 | 40 | 11 | 47 | 0 / 2 | |
| 171 | 3.1B EUR (≈$3.4B) | 42 | 67 | 25 | 63 | 2 / 2 | |
| 171 | 4.1B USD | 42 | 8 | — | 22 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score